Logo for Aptose Biosciences Inc

Aptose Biosciences Investor Relations Material

Latest events

Logo for Aptose Biosciences Inc

Q3 2023

Aptose Biosciences
Logo for Aptose Biosciences

Q3 2023

9 Nov, 2023
Logo for Aptose Biosciences

Study Update

30 Oct, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Aptose Biosciences Inc., a biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United States. In addition, the company is developing product candidates using Allogeneic Natural Killer Cell Pharmacological Chimeric Receptors (NK-PRRs) to treat cancer, with NK-PRR strategies designed to target specific tumor antigens. The company's mission is to deliver therapies that fit the precise characteristics of individual patients, by providing tailor-made, autologous treatments that harness a patient’s own immune system cells to fight disease.